Fundamental dimension Equity attribute | FHTXPeer $2.00▼-0.50% Cap $118.8MP/E -2.0x QuantScore40/100 | ARCTPeer $9.84▼-8.29% Cap $279.7MP/E -3.0x QuantScore48/100 | ASMBLeader $19.84▼-2.17% Cap $404.0MP/E 36.1x QuantScore58/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
43/100 |
47/100 |
39/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 33/100 | 37/100 |
Health Piotroski, Altman Z, leverage & liquidity | 54/100 | 50/100 | 75/100 |
Growth Revenue / earnings growth & margins | 47/100 | 30/100 | 75/100 |
Sentiment Analyst ratings, targets & revisions | 54/100 | 82/100 | 64/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -2.0x | -3.0x | 36.1x |
Forward P/E (next FY) | -2.2x | -2.9x | -32.6x |
EV / EBITDA (TTM) | -1.5x | -1.4x | 5500.3x |
Price / Sales | 3.2x | 11.8x | 5.4x |
Price / Free Cash Flow | -1.4x | -3.8x | -10.5x |
PEG ratio | -0.11 | 0.08 | 0.05 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 1 / 9 | 2 / 9 |
Altman Z-Score | -4.45 (Distress) | -0.60 (Distress) | 7.38 (Safe) |
Total debt / equity | -0.53 | 0.13 | 0.01 |
Quick ratio | 3.4x | 5.9x | 14.0x |
Interest coverage | — | — | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +36.8% | -51.4% | +153.5% |
Net income growth YoY | +14.2% | +18.7% | +84.8% |
Gross margin (TTM) | 42.7% | 83.2% | 77.7% |
Operating margin (FY) | -265.6% | -111.5% | -16.8% |
FCF margin (FY) | -278.7% | -110.5% | -56.9% |
5. Trailing price performancePrice change over period |
1M return | -44.4% | -30.3% | -16.1% |
3M return | -58.8% | +77.9% | -22.3% |
6M return | -62.3% | +14.6% | -28.8% |
Year to date | -63.0% | +60.5% | -41.7% |
1Y return | -50.9% | -12.3% | -32.1% |
3Y return | -36.5% | -50.5% | +87.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-14.01 -800.5% premium | $-4.03 -141.0% premium | $-54.12 -372.8% premium |
Wall Street consensus target | $4.00 +100.0% · range $2.00–$5.00 | $30.50 +210.0% · range $20.00–$41.00 | $51.67 +160.4% · range $50.00–$53.00 |
Consensus stance | 67% Buy33% Hold0% Sell | 57% Buy24% Hold19% Sell | 55% Buy45% Hold0% Sell |